News
Like Viagra, Stendra, and Levitra, Cialis (the brand name of the active ingredient tadalafil) is highly effective as a ...
Rates of Raynaud phenomenon medication initiation are low among patients with SSc in the United States, with less than one-third receiving consistent treatment.
MOST PEOPLE THINK of ED as a problem for older guys, but that’s not always the case. Data show that about 13 percent of men ...
One of the more serious side effects from immune checkpoint inhibitor (ICI) therapies for cancer is new-onset or worsened ...
A doctor has issued an important health warning to Oasis fans as thousands are expected to head to Heaton Park tonight ...
Postoperative penile hypoxia is one potential contributor, Pedersen and co-authors noted. The rationale for LI-SWT to treat ...
Both patients with IPF and patients with PPF treated with nerandomilast demonstrated a smaller decline in forced vital ...
Merck & Co – known as MSD outside of the US and Canada – has announced that it will be expanding its respiratory diseases ...
Pulmonary Hypertension associated with Interstitial Lung Disease Market Insight, Epidemiology And Market Forecast - 2034The pulmonary hypert ...
6d
GlobalData on MSNMerck agrees to acquire Verona Pharma for $10bnThe transaction will enhance Merck's cardio-pulmonary pipeline and portfolio with the addition of Ohtuvayre, an FDA-approved COPD treatment.
Merck & Co. has agreed to acquire Verona Pharma for $10 billion, the companies said, in a deal designed to expand the pharma giant’s pipeline and portfolio of cardio-pulmonary disease treatments.
Merck, a German drugmaker, revealed on Wednesday that it has finalized a deal to purchase the UK-headquartered Verona Pharma for $10 billion, or $107 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results